Treatments - Bamlanivimab

Bamlanivimab was produced by Ely Lilly and purchased by the federal government for distribution across the country. It shows promise in helping reduce hospitalizations of high-risk patients who have contracted the virus. 

CHI Health has received a limited supply of Bamlanivimab to be administered at multiple sites across Nebraska, Western Iowa, and Bismarck, ND. It will only be given as an intravenous infusion at a dedicated infusion clinic only.  You must have a referral and order from a provider in order to receive this medication.

Requirements for administration:

  • Must be 12 years or older.
  • Must have a confirmed positive SARS-CoV-2 (COVID-19) virus test AND be at High Risk for Hospitalization.
  • Must have a physician referral.

Talk with Your Provider

If you have tested positive and are curious if you qualify for treatment, consult with your provider first.  If you do not have a primary care provider, you may schedule a virtual appointment through our Virtual Quick Care.